These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 37970124)

  • 1. Partners in diabetes epidemic: A global perspective.
    Wang H; Akbari-Alavijeh S; Parhar RS; Gaugler R; Hashmi S
    World J Diabetes; 2023 Oct; 14(10):1463-1477. PubMed ID: 37970124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Dietary Fibre in Modulating Gut Microbiota Dysbiosis in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    Ojo O; Feng QQ; Ojo OO; Wang XH
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-based care for the management of type 2 diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(23):1-40. PubMed ID: 23074528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural interventions for type 2 diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(21):1-45. PubMed ID: 23074526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bariatric surgery for people with diabetes and morbid obesity: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(22):1-23. PubMed ID: 23074527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of botanical fermented foods on metabolic biomarkers and gut microbiota in adults with metabolic syndrome and type 2 diabetes: a systematic review protocol.
    Chan M; Baxter H; Larsen N; Jespersen L; Ekinci EI; Howell K
    BMJ Open; 2019 Jul; 9(7):e029242. PubMed ID: 31366656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome.
    Ussar S; Fujisaka S; Kahn CR
    Mol Metab; 2016 Sep; 5(9):795-803. PubMed ID: 27617202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A protocol for systematic review and meta-analysis.
    Zheng Y; Ding Q; Zhang L; Gou X; Wei Y; Li M; Tong X
    Medicine (Baltimore); 2020 Sep; 99(38):e22233. PubMed ID: 32957365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the Role of the Gut Microbiome in Diabetes and Therapeutics Targeting Leaky Gut: A Systematic Review.
    Sadagopan A; Mahmoud A; Begg M; Tarhuni M; Fotso M; Gonzalez NA; Sanivarapu RR; Osman U; Latha Kumar A; Mohammed L
    Cureus; 2023 Jul; 15(7):e41559. PubMed ID: 37554593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global research trends on the links between the gut microbiota and diabetes between 2001 and 2021: A bibliometrics and visualized study.
    Zhang B; Jin Z; Zhai T; Ding Q; Yang H; Wang J; Zhang L; Zhao L
    Front Microbiol; 2022; 13():1011050. PubMed ID: 36246235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes.
    Woldaregay AZ; Årsand E; Walderhaug S; Albers D; Mamykina L; Botsis T; Hartvigsen G
    Artif Intell Med; 2019 Jul; 98():109-134. PubMed ID: 31383477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
    Brunkwall L; Orho-Melander M
    Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis.
    Bock PM; Telo GH; Ramalho R; Sbaraini M; Leivas G; Martins AF; Schaan BD
    Diabetologia; 2021 Jan; 64(1):26-41. PubMed ID: 33047170
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.